Almirall (ALM)

Currency in EUR
12.960
-0.040(-0.31%)
Closed·
ALM is included in our AI-picked strategies. See how they work
Fair Value
Day's Range
12.86013.060
52 wk Range
8.03013.400
Key Statistics
Prev. Close
12.96
Open
12.96
Day's Range
12.86-13.06
52 wk Range
8.03-13.4
Volume
265.89K
Average Volume (3m)
151.65K
1-Year Change
58.63%
Book Value / Share
6.87
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
ALM Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
13.873
Upside
+7.04%
Members' Sentiments
Bearish
Bullish
ProTips
Trading at a high earnings multiple

Almirall News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Buy
Technical Indicators
Buy
Moving Averages
Buy

Almirall Company Profile

Almirall, S.A. operates as a skin health-focused biopharmaceutical company in Spain, Europe, the Middle East, the United States, Asia, and Africa. The company offers its products for skin diseases comprising Psoriasis, atopic dermatitis, acne, actinic keratosis, onychomycosis, androgenic alopecia, oncodermatology, and orphan indications, as well as for alimentary tract and metabolism; antiinfectives for systemic use; cardiovascular, musculo-skeletal, nervous, and respiratory system; dermatologicals; genito urinary system and sex hormones; immunostimulants; metabolism; and systematic hormonal preparations. It has a multi-target partnership with Etherna to research and develop mRNA-based therapies for medical dermatology. The company was formerly known as Laboratorios Almirall, S.A. and changed its name to Almirall, S.A. in May 2009. Almirall, S.A. was founded in 1943 and is headquartered in Barcelona, Spain.

Employees
2026
Market
Spain

Almirall Earnings Call Summary for Q2/2025

  • Net sales up 13% YoY in Q2 2025; EBITDA grew 17% to €121.8M. Full-year guidance maintained.
  • R&D spending increased 27% to 12.8% of net sales, focusing on innovation and pipeline expansion.
  • Targeting double-digit net sales CAGR through 2030 and 25% EBITDA margin by 2028.
  • Over 400,000 patients treated with new dermatological products in 2025, strengthening market position.
  • Stock price up 0.83% post-announcement; 227% gain over past six months. P/E ratio favorable vs. growth potential.
Last Updated: 14/10/2025, 18:58
Read Full Transcript

Compare ALM to Peers and Sector

Metrics to compare
ALM
Peers
Sector
Relationship
P/E Ratio
66.2x24.7x−0.6x
PEG Ratio
-0.000.00
Price/Book
1.9x4.3x2.6x
Price / LTM Sales
2.6x3.9x3.2x
Upside (Analyst Target)
4.2%12.6%41.8%
Fair Value Upside
Unlock16.2%5.1%Unlock

Analyst Ratings

8 Buy
3 Hold
0 Sell
Ratings:
11 analysts
Overall Consensus
Buy

Analysts 12-Month Price Target:

Average 13.873
(+7.04% Upside)
Firm
ArticlePositionPrice TargetUpside / DownsideFrom Price TargetActionDate
Stifel
Buy14.50+11.88%-New Coverage14/10/2025
Deutsche Bank
Buy14.00+8.02%12.00Maintain28/07/2025
RBC Capital
Buy12.50-3.55%-Maintain27/05/2025
RBC Capital
Buy12.50-3.55%12.25Maintain25/02/2025
BNP Paribas Exane
Buy10.60-18.21%-Upgrade23/01/2025

Dividends

Payout Ratio
Payout ratio (TTM)
Earnings retained
EPS 0.20%
Dividend Yield
1.15%
Industry Median 2.64%
Annualised payout
0.15
Paid annually
5-Years Growth
-
Growth Streak

Earnings

Latest Release
Nov 10, 2025
EPS / Forecast
0.13 / 0.13
Revenue / Forecast
260.20M / 260.80M
EPS Revisions
Last 90 days

People Also Watch

1.2800
ADXR
-0.62%
18.380
EBRO
-0.86%
2.342
ENC
+1.47%
109.60
BIOX
-1.17%

FAQ

What Is the Almirall (ALM) Share Price Today?

The live Almirall share price today is 12.960

What Stock Exchange Does Almirall (ALM) Trade On?

Almirall is listed and trades on the Madrid Stock Exchange.

What Is the Ticker (Stock Symbol) for Almirall?

The stock symbol (also called a 'ticker') for Almirall is "ALM."

Does Almirall Pay Dividends? What’s The Current ALM Dividend Yield?

Yes, ALM Pays Dividends to its Shareholders. The current Almirall dividend yield is 1.15%.

What Is the Current Almirall Market Cap?

As of today, Almirall market capitalisation is 2.78B.

What Is Almirall's (ALM) Earnings Per Share (TTM)?

The Almirall EPS is currently 0.20 (Trailing Twelve Months).

When Is the Next Almirall Earnings Date?

Almirall's next earnings report will be released on 23 Feb 2026.

Is ALM a Buy or Sell From a Technical Analyst Perspective?

Based on today's Almirall moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.

How Many Times Has Almirall Stock Split?

Almirall has split 4 times. (See the ALM stock split history page for full effective split date and price information.)

How Many Employees Does Almirall Have?

Almirall has 2026 employees.

What is the current trading status of Almirall (ALM)?

As of 24 Dec 2025, Almirall (ALM) is trading at a price of 12.960, with a previous close of 12.960. The stock has fluctuated within a day range of 12.860 to 13.060, while its 52-week range spans from 8.030 to 13.400.

What Is Almirall (ALM) Price Target According to Analysts?

The average 12-month price target for Almirall is EUR13.87273, with a high estimate of EUR17.5 and a low estimate of EUR12.5. 8 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Buy. The stock has an +7.04% Upside potential.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2025 - Fusion Media Limited. All Rights Reserved.